Park Medi World Q4 FY’26 net profit INR 768 mn, up 47% YoY; revenue INR 4,604 mn
Park Medi World · Healthcare Services
Key highlights
- Q4 FY’26 revenue from operations INR 4,604 mn vs INR 3,539 mn in Q4 FY’25 (30% YoY); net profit INR 768 mn vs INR 524 mn (47% YoY).
- 610 beds added in FY’26 via acquisitions in Bhatinda (250 beds) and Agra (360 beds), taking capacity to 3,610 beds as of 31st March 2026.
- Panchkula hospital (350 beds) commissioned on 10th Apr’26, taking capacity to 3,960 beds as on date; Febris hospital (200 beds) in Narela acquired, commissioning expected in Q2 FY’27.
Why it's rated notable: the year-on-year change is 47% (20% to 50%)
Figures checked against the filing by a second AI read, which corrected the first summary. About the business, not the share price.
Original filing
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Aerospace & Defense
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Park Medi World
- Acquisition / mergerNotablePark Medi World Q1 FY27 net profit up 35% YoY; Mehar Hospital deal signed
- Acquisition / mergerNotablePark Medi World Limited acquires 80% stake in V3 Healthcare Private Limited
- Financial resultsNotablePark Medi World Limited reports audited FY 2025-26 results; acquisitions of KPS and SVPD
- Capex / expansionNotablePark Group launches Panchkula hospital, expands Mohali facility to grow network
- Acquisition / mergerNotablePark Medi World completes acquisition of SVPD Healthcare Private Limited
Other capex / expansion filings this fortnight
- Maharaja & Speedex India Limited raises manufacturing capacity to 72 lakh units/year
- Elin Electronics Q2 FY27 earnings report with 10% revenue growth and margin update
- HOAC Foods India Limited H1 FY27 Earnings Call Transcript dated November 5, 2026
- Gujarat State Fertilizers & Chemicals Limited Q2 FY27 Earnings Call Highlights
- Supriya Lifescience H1 revenue up 14.8% to ₹396.04 crore; Q2 profit falls
- V-MARC India Ltd announces Q2 & H1 FY27 unaudited financial results and review report
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- Aster DM QualityGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.